Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Carlsmed Raises FY2025 Sales Guidance from $45.500M-$47.500M to $49.000M-$50.000M vs $46.660M Est

Author: Benzinga Newsdesk | November 06, 2025 04:12pm
Carlsmed (NASDAQ:CARL) raises FY2025 sales outlook from $45.500 million-$47.500 million to $49.000 million-$50.000 million vs $46.660 million estimate.

Posted In: CARL


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist